Supreeth Guptha

872 total citations
9 papers, 251 citations indexed

About

Supreeth Guptha is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Supreeth Guptha has authored 9 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Supreeth Guptha's work include Cancer therapeutics and mechanisms (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Antibiotic Resistance in Bacteria (2 papers). Supreeth Guptha is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Tuberculosis Research and Epidemiology (6 papers) and Antibiotic Resistance in Bacteria (2 papers). Supreeth Guptha collaborates with scholars based in India, United States and United Kingdom. Supreeth Guptha's co-authors include Vasanthi Ramachandran, Sreevalli Sharma, Manoranjan Panda, Vasan K. Sambandamurthy, Parvinder Kaur, Ashwini Narayan, Anisha Ambady, Anandkumar Raichurkar, Vaishali Humnabadkar and Suresh Rudrapatna and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Supreeth Guptha

9 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Supreeth Guptha India 7 147 119 111 43 25 9 251
Anandkumar Raichurkar India 10 207 1.4× 158 1.3× 163 1.5× 52 1.2× 47 1.9× 11 350
Claire J. Mackenzie United Kingdom 6 173 1.2× 95 0.8× 84 0.8× 59 1.4× 38 1.5× 9 258
Vaishali Humnabadkar India 7 171 1.2× 139 1.2× 84 0.8× 45 1.0× 29 1.2× 8 248
Jeong Jea Seo South Korea 6 154 1.0× 84 0.7× 107 1.0× 48 1.1× 21 0.8× 7 251
Baptiste Villemagne France 9 200 1.4× 153 1.3× 109 1.0× 53 1.2× 45 1.8× 14 357
Fátima Ortega Spain 10 140 1.0× 170 1.4× 83 0.7× 137 3.2× 35 1.4× 14 304
Sean Trapp United States 5 149 1.0× 75 0.6× 207 1.9× 32 0.7× 15 0.6× 5 403
Kenia Pissinate Brazil 11 158 1.1× 148 1.2× 174 1.6× 74 1.7× 39 1.6× 24 362
Vijender Panduga India 7 111 0.8× 143 1.2× 59 0.5× 76 1.8× 20 0.8× 8 244
Eva María López-Román Spain 9 123 0.8× 143 1.2× 94 0.8× 48 1.1× 27 1.1× 9 255

Countries citing papers authored by Supreeth Guptha

Since Specialization
Citations

This map shows the geographic impact of Supreeth Guptha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supreeth Guptha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supreeth Guptha more than expected).

Fields of papers citing papers by Supreeth Guptha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supreeth Guptha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supreeth Guptha. The network helps show where Supreeth Guptha may publish in the future.

Co-authorship network of co-authors of Supreeth Guptha

This figure shows the co-authorship network connecting the top 25 collaborators of Supreeth Guptha. A scholar is included among the top collaborators of Supreeth Guptha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Supreeth Guptha. Supreeth Guptha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kaur, Parvinder, Santanu Datta, Radha Krishan Shandil, et al.. (2016). Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense. PLoS ONE. 11(5). e0154513–e0154513. 6 indexed citations
2.
Ramachandran, Vasanthi, Anupriya Kumar, João Neres, et al.. (2016). Nitroarenes as Antitubercular Agents: Stereoelectronic Modulation to Mitigate Mutagenicity. ChemMedChem. 11(3). 331–339. 20 indexed citations
3.
Ravishankar, Sudha, Anisha Ambady, Disha Awasthy, et al.. (2015). Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target. Tuberculosis. 95(5). 589–598. 32 indexed citations
4.
Naik, Maruti, Sandeep R. Ghorpade, Ashwini Narayan, et al.. (2014). 2-Phenylindole and Arylsulphonamide: Novel Scaffolds Bactericidal against Mycobacterium tuberculosis. ACS Medicinal Chemistry Letters. 5(9). 1005–1009. 24 indexed citations
5.
Sharma, Sreevalli, Parvinder Kaur, Supreeth Guptha, et al.. (2014). Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis. ACS Medicinal Chemistry Letters. 5(5). 491–495. 3 indexed citations
6.
Humnabadkar, Vaishali, K Prabhakar, Ashwini Narayan, et al.. (2014). UDP- N -Acetylmuramic Acid l -Alanine Ligase (MurC) Inhibition in a tolC Mutant Escherichia coli Strain Leads to Cell Death. Antimicrobial Agents and Chemotherapy. 58(10). 6165–6171. 9 indexed citations
7.
Naik, Maruti, Anisha Ambady, Ashwini Narayan, et al.. (2014). Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System. Journal of Medicinal Chemistry. 57(15). 6572–6582. 41 indexed citations
8.
Panda, Manoranjan, Vasanthi Ramachandran, Pravin S. Shirude, et al.. (2014). Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity. Journal of Medicinal Chemistry. 57(11). 4761–4771. 82 indexed citations
9.
Panda, Manoranjan, Kakoli Mukherjee, Subramanyam J. Tantry, et al.. (2013). Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series. Bioorganic & Medicinal Chemistry Letters. 23(17). 4996–5001. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026